P1.01-92 A Phase II Study of Afatinib Treatment for Elderly Patients with Previously Untreated Advanced NSCLC Harboring EGFR Mutations

Autor: Suzuki, K., Imai, H., Kaira, K., Anzai, M., Tsuda, T., Ishizuka, T., Kuwako, T., Naruse, I., Nemoto, K., Uchino, J., Morozumi, N., Ishihara, S., Minato, K., Hisada, T.
Zdroj: In Journal of Thoracic Oncology October 2018 13(10) Supplement:S498-S498
Databáze: ScienceDirect